Brief: ABVC Biopharma Provides Vitargus Update

ABVC Biopharma

30/06/2022 13:31

June 30 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA PROVIDES VITARGUS® UPDATE
    * ABVC BIOPHARMA - VITARGUS PHASE II CLINICAL STUDY PROTOCOL
BEEN
APPROVED BY CENTRAL RESEARCH ETHICS COMMITTEE OF NATIONAL
RESEARCH COUNCIL OF THAILAND

Source text for Eikon:  ID:nGNX11GYkH 
Further company coverage:  ABVC.O